|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.14 CNY | +2.50% |
|
-0.49% | -42.67% |
Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718) agreed to acquire 55% stake in Shaanxi Reshine Biotech Co. Ltd. from Maylion Management Limited on June 11, 2024. The estimated deal value is CNY 880-960 million.
The transaction has been approved by the board of Shanghai Hile.
| 1st Jan change | Capi. | |
|---|---|---|
| -42.67% | 556M | |
| -11.35% | 79.83B | |
| -4.56% | 7.03B | |
| +21.00% | 3.57B | |
| +0.42% | 3.27B | |
| -7.81% | 1.21B | |
| -36.21% | 1.06B | |
| -38.70% | 1.02B | |
| -32.68% | 877M | |
| -18.12% | 854M |
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. 
